DOI: 10.1016/s0022-3565(24)37076-4. Human CYP2C9 and CYP2A6 Mediate Formation of the Hepatotoxin 4-Ene-Valproic Acid

Human CYP2C9 and CYP2A6 Mediate Formation of the Hepatotoxin 4-Ene-Valproic Acid

10.1016/s0022-3565(24)37076-4

Crossref journal-article

Elsevier BV

The Journal of Pharmacology and Experimental Therapeutics (78)

Bibliography

Sadeque, A. J. M., Fisher, M. B., Korzekwa, K. R., Gonzalez, F. J., & Rettie, A. E. (1997). Human CYP2C9 and CYP2A6 Mediate Formation of the Hepatotoxin 4-Ene-Valproic Acid. The Journal of Pharmacology and Experimental Therapeutics, 283(2), 698â703.

Authors 5

Abu J.M. Sadeque (first)
Michael B. Fisher (additional)
Kenneth R. Korzekwa (additional)
Frank J. Gonzalez (additional)
Allan E. Rettie (additional)

References 37 Referenced 78

10.1111/j.1365-2125.1993.tb00410.x / Br. J. Clin. Pharmacol. / Identification of human liver cytochrome P-450 isoforms mediating omeprazole metabolism. by Anderson (1993)
10.1002/mc.2940020405 / Mol. Carcinog. / Human cDNA-expressed cytochrome P450 1A2: Mutagen activation and substrate specificity. by Aoyama (1989)
10.1021/tx00004a001 / Chem. Res. Toxicol. / Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acid. by Baillie (1988)
10.1007/BF01962701 / Pharm. Weekbl. Sci. / Metabolism of valproate to hepatotoxic intermediates. by Baillie (1992)
10.1212/WNL.46.2.465 / Neurology / Valproic acid hepatic fatalities. III. U. S. experience since 1986. by Bryant (1996)
10.1016/S0090-9556(25)06652-8 / Drug Metab. Dispos. / Induction of liver microsomal cytochrome P450 in cynomologus monkeys. by Bullock (1995)
10.1002/bms.1200100702 / Biomed Mass Spectrom. / A sensitive and specific stable isotope assay for warfarin and its metabolites. by Bush (1983)
10.1006/abbi.1994.1259 / Arch. Biochem. Biophys. / Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochrome P-450. by Chang (1994)
10.1042/bj0960390 / Biochem. J. / A spectrofluorimetric study of the 7-hydroxylation of coumarin by liver microsomes. by Creaven (1965)
10.1002/mc.2940030104 / Mol. Carcinog. / Stable expression of human cytochrome P4501A2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B1. by Crespi (1990)
10.1212/WNL.37.3.379 / Neurology / Valproic acid hepatic fatalities: a retrospective review. by Dreifuss (1987)
{'key': '10.1016/S0022-3565(24)37076-4_bib12', 'first-page': '303', 'article-title': 'The spectroscopic measurement of cytochromes associated with drug metabolism.', 'volume': '2', 'author': 'Estabrook', 'year': '1972', 'journal-title': 'Methods Pharmacol.'} / Methods Pharmacol. / The spectroscopic measurement of cytochromes associated with drug metabolism. by Estabrook (1972)
10.1016/S0022-3476(79)80110-9 / J. Pediatr. / Reye-like syndrome associated with valproic acid. by Gerber (1979)
10.1016/S0090-9556(25)08445-4 / Drug Metab. Dispos. / Relationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes. by Hall (1994)
10.1016/S0090-9556(25)07237-X / Drug Metab. Dispos. / Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9. by Jones (1996)
10.1016/0300-483X(96)03352-5 / Toxicology / Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes. by JurimaRomet (1996)
10.1016/0009-2797(94)90014-0 / Chem. Biol. Interact. / Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes. by Kassahun (1994)
10.1111/j.1528-1157.1994.tb02546.x / Epilepsia / Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. by König (1994)
10.1002/chir.530020207 / Chirality / Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: a major oxidative metabolite of (+)-R-warfarin from hepatic microsomal preparations. by Lawrence (1990)
10.1038/clpt.1990.144 / Clin. Pharmacol. Ther. / Effects of polytherapy with phenytoin carbamazepine and stiripentol on formation of 4 ene-valproate, a hepatotoxic metabolite of valproic acid. by Levy (1990)
10.1016/S0021-9258(19)52451-6 / J. Biol. Chem. / Protein measurement with the Folin phenol reagent. by Lowry (1951)
10.1021/bi00033a007 / Biochemistry / The substrate binding site of human liver cytochrome P450 2C9 - an approach using designed tienilic acid derivatives and molecular modelling. by Mancy (1995)
10.1021/bi00475a012 / Biochemistry / The human CYP2F gene subfamily: Identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression and chromosome mapping. by Nhamburo (1990)
10.1016/0003-9861(92)90115-D / Arch. Biochem. Biophys. / Species differences and inter-individual variation in liver microsomal cytochrome P450 2A (CYP2A) enzymes: Effects on coumarin, dicoumarol and testosterone oxidation. by Pearce (1992)
10.1016/S0090-9556(25)08600-3 / Drug Metab. Disp. / Cyclosporin A drug interactions: Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary culture of human hepatocytes and in liver microsomes. by Pichard (1990)
10.1016/S0090-9556(25)08857-9 / Drug Metab. Dispos. / Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid. by Rettenmeier (1986)
10.1126/science.3101178 / Science / Cytochrome P450-catalyzed formation of Δ4 VPA, a toxic metabolite of valproic acid. by Rettie (1987)
10.1016/S0021-9258(18)68302-4 / J. Biol. Chem. / Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. by Rettie (1988)
10.1016/S0090-9556(25)08754-9 / Drug Metab. Dispos. / Characteristics of warfarin hydroxylation catalyzed by human liver microsomes. by Rettie (1989)
10.1021/bi00024a013 / Biochemistry / CYP4 isozyme specificity and the relationship between ω-hydroxylation and terminal desaturation of valproic acid. by Rettie (1995)
10.1016/S0090-9556(25)08803-8 / Drug Metab. Dispos. / Stereoselective sulfoxidation by human flavin-containing monooxygenases: Evidence for catalytic diversity between hepatic, renal and fetal forms. by Sadeque (1992)
10.1016/S0090-9556(25)07459-8 / Drug Metab. Dispos. / Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes. by Shirley (1993)
10.1007/BF01962700 / Pharm. Weekbl. Sci. / Valproate hepatotoxicity syndrome: hypotheses of pathogenesis. by Stephens (1992)
10.1021/tx00047a006 / Chem. Res. Toxicol. / Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status. by Tang (1995)
10.1073/pnas.82.18.6310 / Proc. Natl. Acad. Sci. U.S.A. / Identification of an inducible form of cytochrome P-450 in human liver. by Watkins (1985)
10.3109/03602539308993982 / Drug Metab. Rev. / In vitro methods for assessing human hepatic drug metabolism: their use in drug development. by Wrighton (1993)
10.1021/bi00457a031 / Biochemistry / The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. by Yamano (1990)

Dates

Type	When
Created	8 months ago (Jan. 4, 2025, 10:57 a.m.)
Deposited	6 months, 2 weeks ago (Feb. 19, 2025, 7:41 p.m.)
Indexed	1 week ago (Aug. 29, 2025, 6:42 a.m.)
Issued	27 years, 10 months ago (Nov. 1, 1997)
Published	27 years, 10 months ago (Nov. 1, 1997)
Published Print	27 years, 10 months ago (Nov. 1, 1997)

Funders 0

None

BibTeX

@article{Sadeque_1997, title={Human CYP2C9 and CYP2A6 Mediate Formation of the Hepatotoxin 4-Ene-Valproic Acid}, volume={283}, ISSN={0022-3565}, url={http://dx.doi.org/10.1016/s0022-3565(24)37076-4}, DOI={10.1016/s0022-3565(24)37076-4}, number={2}, journal={The Journal of Pharmacology and Experimental Therapeutics}, publisher={Elsevier BV}, author={Sadeque, Abu J.M. and Fisher, Michael B. and Korzekwa, Kenneth R. and Gonzalez, Frank J. and Rettie, Allan E.}, year={1997}, month=nov, pages={698–703} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        29
      ]
    ],
    "date-time": "2025-08-29T10:42:11Z",
    "timestamp": 1756464131889,
    "version": "3.37.3"
  },
  "reference-count": 37,
  "publisher": "Elsevier BV",
  "issue": "2",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1997,
            11,
            1
          ]
        ],
        "date-time": "1997-11-01T00:00:00Z",
        "timestamp": 878342400000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    },
    {
      "start": {
        "date-parts": [
          [
            1997,
            11,
            1
          ]
        ],
        "date-time": "1997-11-01T00:00:00Z",
        "timestamp": 878342400000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/legal/tdmrep-license"
    }
  ],
  "content-domain": {
    "domain": [
      "jpet.aspetjournals.org",
      "elsevier.com",
      "sciencedirect.com"
    ],
    "crossmark-restriction": true
  },
  "published-print": {
    "date-parts": [
      [
        1997,
        11
      ]
    ]
  },
  "DOI": "10.1016/s0022-3565(24)37076-4",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2025,
        1,
        4
      ]
    ],
    "date-time": "2025-01-04T15:57:00Z",
    "timestamp": 1736006220000
  },
  "page": "698-703",
  "update-policy": "https://doi.org/10.1016/elsevier_cm_policy",
  "source": "Crossref",
  "is-referenced-by-count": 78,
  "title": "Human CYP2C9 and CYP2A6 Mediate Formation of the Hepatotoxin 4-Ene-Valproic Acid",
  "prefix": "10.1016",
  "volume": "283",
  "author": [
    {
      "given": "Abu J.M.",
      "family": "Sadeque",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Michael B.",
      "family": "Fisher",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Kenneth R.",
      "family": "Korzekwa",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Frank J.",
      "family": "Gonzalez",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Allan E.",
      "family": "Rettie",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "521",
      "DOI": "10.1111/j.1365-2125.1993.tb00410.x",
      "article-title": "Identification of human liver cytochrome P-450 isoforms mediating omeprazole metabolism.",
      "volume": "36",
      "author": "Anderson",
      "year": "1993",
      "journal-title": "Br. J. Clin. Pharmacol."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "192",
      "DOI": "10.1002/mc.2940020405",
      "article-title": "Human cDNA-expressed cytochrome P450 1A2: Mutagen activation and substrate specificity.",
      "volume": "2",
      "author": "Aoyama",
      "year": "1989",
      "journal-title": "Mol. Carcinog."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "DOI": "10.1021/tx00004a001",
      "article-title": "Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acid.",
      "volume": "1",
      "author": "Baillie",
      "year": "1988",
      "journal-title": "Chem. Res. Toxicol."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "122",
      "DOI": "10.1007/BF01962701",
      "article-title": "Metabolism of valproate to hepatotoxic intermediates.",
      "volume": "14",
      "author": "Baillie",
      "year": "1992",
      "journal-title": "Pharm. Weekbl. Sci."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "465",
      "DOI": "10.1212/WNL.46.2.465",
      "article-title": "Valproic acid hepatic fatalities. III. U. S. experience since 1986.",
      "volume": "46",
      "author": "Bryant",
      "year": "1996",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "736",
      "DOI": "10.1016/S0090-9556(25)06652-8",
      "article-title": "Induction of liver microsomal cytochrome P450 in cynomologus monkeys.",
      "volume": "23",
      "author": "Bullock",
      "year": "1995",
      "journal-title": "Drug Metab. Dispos."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "395",
      "DOI": "10.1002/bms.1200100702",
      "article-title": "A sensitive and specific stable isotope assay for warfarin and its metabolites.",
      "volume": "10",
      "author": "Bush",
      "year": "1983",
      "journal-title": "Biomed Mass Spectrom."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "437",
      "DOI": "10.1006/abbi.1994.1259",
      "article-title": "Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochrome P-450.",
      "volume": "311",
      "author": "Chang",
      "year": "1994",
      "journal-title": "Arch. Biochem. Biophys."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "390",
      "DOI": "10.1042/bj0960390",
      "article-title": "A spectrofluorimetric study of the 7-hydroxylation of coumarin by liver microsomes.",
      "volume": "96",
      "author": "Creaven",
      "year": "1965",
      "journal-title": "Biochem. J."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "DOI": "10.1002/mc.2940030104",
      "article-title": "Stable expression of human cytochrome P4501A2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B1.",
      "volume": "3",
      "author": "Crespi",
      "year": "1990",
      "journal-title": "Mol. Carcinog."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "379",
      "DOI": "10.1212/WNL.37.3.379",
      "article-title": "Valproic acid hepatic fatalities: a retrospective review.",
      "volume": "37",
      "author": "Dreifuss",
      "year": "1987",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib12",
      "first-page": "303",
      "article-title": "The spectroscopic measurement of cytochromes associated with drug metabolism.",
      "volume": "2",
      "author": "Estabrook",
      "year": "1972",
      "journal-title": "Methods Pharmacol."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "142",
      "DOI": "10.1016/S0022-3476(79)80110-9",
      "article-title": "Reye-like syndrome associated with valproic acid.",
      "volume": "95",
      "author": "Gerber",
      "year": "1979",
      "journal-title": "J. Pediatr."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "975",
      "DOI": "10.1016/S0090-9556(25)08445-4",
      "article-title": "Relationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.",
      "volume": "22",
      "author": "Hall",
      "year": "1994",
      "journal-title": "Drug Metab. Dispos."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/S0090-9556(25)07237-X",
      "article-title": "Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9.",
      "volume": "24",
      "author": "Jones",
      "year": "1996",
      "journal-title": "Drug Metab. Dispos."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "DOI": "10.1016/0300-483X(96)03352-5",
      "article-title": "Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes.",
      "volume": "112",
      "author": "JurimaRomet",
      "year": "1996",
      "journal-title": "Toxicology"
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "253",
      "DOI": "10.1016/0009-2797(94)90014-0",
      "article-title": "Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes.",
      "volume": "90",
      "author": "Kassahun",
      "year": "1994",
      "journal-title": "Chem. Biol. Interact."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "1005",
      "DOI": "10.1111/j.1528-1157.1994.tb02546.x",
      "article-title": "Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.",
      "volume": "35",
      "author": "K\u00f6nig",
      "year": "1994",
      "journal-title": "Epilepsia"
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "96",
      "DOI": "10.1002/chir.530020207",
      "article-title": "Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: a major oxidative metabolite of (+)-R-warfarin from hepatic microsomal preparations.",
      "volume": "2",
      "author": "Lawrence",
      "year": "1990",
      "journal-title": "Chirality"
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "DOI": "10.1038/clpt.1990.144",
      "article-title": "Effects of polytherapy with phenytoin carbamazepine and stiripentol on formation of 4 ene-valproate, a hepatotoxic metabolite of valproic acid.",
      "volume": "48",
      "author": "Levy",
      "year": "1990",
      "journal-title": "Clin. Pharmacol. Ther."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "265",
      "DOI": "10.1016/S0021-9258(19)52451-6",
      "article-title": "Protein measurement with the Folin phenol reagent.",
      "volume": "193",
      "author": "Lowry",
      "year": "1951",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "10365",
      "DOI": "10.1021/bi00033a007",
      "article-title": "The substrate binding site of human liver cytochrome P450 2C9 - an approach using designed tienilic acid derivatives and molecular modelling.",
      "volume": "34",
      "author": "Mancy",
      "year": "1995",
      "journal-title": "Biochemistry"
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "5491",
      "DOI": "10.1021/bi00475a012",
      "article-title": "The human CYP2F gene subfamily: Identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression and chromosome mapping.",
      "volume": "29",
      "author": "Nhamburo",
      "year": "1990",
      "journal-title": "Biochemistry"
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "211",
      "DOI": "10.1016/0003-9861(92)90115-D",
      "article-title": "Species differences and inter-individual variation in liver microsomal cytochrome P450 2A (CYP2A) enzymes: Effects on coumarin, dicoumarol and testosterone oxidation.",
      "volume": "298",
      "author": "Pearce",
      "year": "1992",
      "journal-title": "Arch. Biochem. Biophys."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "595",
      "DOI": "10.1016/S0090-9556(25)08600-3",
      "article-title": "Cyclosporin A drug interactions: Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary culture of human hepatocytes and in liver microsomes.",
      "volume": "18",
      "author": "Pichard",
      "year": "1990",
      "journal-title": "Drug Metab. Disp."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "443",
      "DOI": "10.1016/S0090-9556(25)08857-9",
      "article-title": "Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.",
      "volume": "14",
      "author": "Rettenmeier",
      "year": "1986",
      "journal-title": "Drug Metab. Dispos."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "890",
      "DOI": "10.1126/science.3101178",
      "article-title": "Cytochrome P450-catalyzed formation of \u03944 VPA, a toxic metabolite of valproic acid.",
      "volume": "235",
      "author": "Rettie",
      "year": "1987",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "13733",
      "DOI": "10.1016/S0021-9258(18)68302-4",
      "article-title": "Cytochrome P-450-catalyzed desaturation of valproic acid in vitro.",
      "volume": "263",
      "author": "Rettie",
      "year": "1988",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "265",
      "DOI": "10.1016/S0090-9556(25)08754-9",
      "article-title": "Characteristics of warfarin hydroxylation catalyzed by human liver microsomes.",
      "volume": "17",
      "author": "Rettie",
      "year": "1989",
      "journal-title": "Drug Metab. Dispos."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "7889",
      "DOI": "10.1021/bi00024a013",
      "article-title": "CYP4 isozyme specificity and the relationship between \u03c9-hydroxylation and terminal desaturation of valproic acid.",
      "volume": "34",
      "author": "Rettie",
      "year": "1995",
      "journal-title": "Biochemistry"
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "832",
      "DOI": "10.1016/S0090-9556(25)08803-8",
      "article-title": "Stereoselective sulfoxidation by human flavin-containing monooxygenases: Evidence for catalytic diversity between hepatic, renal and fetal forms.",
      "volume": "20",
      "author": "Sadeque",
      "year": "1992",
      "journal-title": "Drug Metab. Dispos."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "580",
      "DOI": "10.1016/S0090-9556(25)07459-8",
      "article-title": "Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes.",
      "volume": "21",
      "author": "Shirley",
      "year": "1993",
      "journal-title": "Drug Metab. Dispos."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "118",
      "DOI": "10.1007/BF01962700",
      "article-title": "Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.",
      "volume": "14",
      "author": "Stephens",
      "year": "1992",
      "journal-title": "Pharm. Weekbl. Sci."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "671",
      "DOI": "10.1021/tx00047a006",
      "article-title": "Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.",
      "volume": "8",
      "author": "Tang",
      "year": "1995",
      "journal-title": "Chem. Res. Toxicol."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib35",
      "doi-asserted-by": "crossref",
      "first-page": "6310",
      "DOI": "10.1073/pnas.82.18.6310",
      "article-title": "Identification of an inducible form of cytochrome P-450 in human liver.",
      "volume": "82",
      "author": "Watkins",
      "year": "1985",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "453",
      "DOI": "10.3109/03602539308993982",
      "article-title": "In vitro methods for assessing human hepatic drug metabolism: their use in drug development.",
      "volume": "25",
      "author": "Wrighton",
      "year": "1993",
      "journal-title": "Drug Metab. Rev."
    },
    {
      "key": "10.1016/S0022-3565(24)37076-4_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "1322",
      "DOI": "10.1021/bi00457a031",
      "article-title": "The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.",
      "volume": "29",
      "author": "Yamano",
      "year": "1990",
      "journal-title": "Biochemistry"
    }
  ],
  "container-title": "The Journal of Pharmacology and Experimental Therapeutics",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0022356524370764?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0022356524370764?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2025,
        2,
        20
      ]
    ],
    "date-time": "2025-02-20T00:41:40Z",
    "timestamp": 1740012100000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0022356524370764"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1997,
        11
      ]
    ]
  },
  "references-count": 37,
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          1997,
          11
        ]
      ]
    }
  },
  "alternative-id": [
    "S0022356524370764"
  ],
  "URL": "http://dx.doi.org/10.1016/S0022-3565(24)37076-4",
  "relation": {},
  "ISSN": [
    "0022-3565"
  ],
  "subject": [],
  "container-title-short": "The Journal of Pharmacology and Experimental Therapeutics",
  "published": {
    "date-parts": [
      [
        1997,
        11
      ]
    ]
  },
  "assertion": [
    {
      "value": "Elsevier",
      "name": "publisher",
      "label": "This article is maintained by"
    },
    {
      "value": "Human CYP2C9 and CYP2A6 Mediate Formation of the Hepatotoxin 4-Ene-Valproic Acid",
      "name": "articletitle",
      "label": "Article Title"
    },
    {
      "value": "The Journal of Pharmacology and Experimental Therapeutics",
      "name": "journaltitle",
      "label": "Journal Title"
    },
    {
      "value": "https://doi.org/10.1016/S0022-3565(24)37076-4",
      "name": "articlelink",
      "label": "CrossRef DOI link to publisher maintained version"
    },
    {
      "value": "article",
      "name": "content_type",
      "label": "Content Type"
    },
    {
      "value": "\u00a9 1997 The American Society for Pharmacology and Experimental Therapeutics",
      "name": "copyright",
      "label": "Copyright"
    }
  ]
}